We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Aptamer Group Plc | LSE:APTA | London | Ordinary Share | GB00BNRRP542 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.025 | -2.0% | 1.225 | 124,322 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 1.15 | 1.30 | 1.225 | 1.225 | 1.225 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 1.75M | -7.84M | -0.0168 | -0.73 | 5.7M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:30:36 | O | 33,358 | 1.225 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 20/11/2023 | 07:00 | UKREG | Aptamer Group PLC Posting of Annual Report and Notice of AGM |
| 09/11/2023 | 18:11 | ALNC |  EARNINGS AND TRADING: Aptamer revenue falls, loss widens |
| 09/11/2023 | 07:00 | UKREG | Aptamer Group PLC Full year results for the 12mths ended 30 Jun 2023 |
| 08/11/2023 | 12:20 | UKREG | Aptamer Group PLC Notice of Results and Investor Presentation |
| 06/11/2023 | 10:59 | ALNC | Aptamer says interim revenue to fall due to weak customer confidence |
| 06/11/2023 | 07:00 | UKREG | Aptamer Group PLC Trading Update |
| 24/10/2023 | 09:16 | UKREG | Aptamer Group PLC Holding(s) in Company |
| 09/10/2023 | 08:40 | UKREG | Aptamer Group PLC Grant of Options and Related Party Transaction |
| 19/9/2023 | 20:57 | ALNC | IN BRIEF: Aptamer raises GBP310,772 through subscription and placing |
| 19/9/2023 | 13:35 | UKREG | Aptamer Group PLC Placing and Subscription, PDMR Dealing and TVR |
Aptamer (APTA) Share Charts1 Year Aptamer Chart |
|
1 Month Aptamer Chart |
Intraday Aptamer Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 08/12/2023 | 09:35 | ☆☆ Aptamer Group - Novel Antibody Mimetics (Optimers) ☆☆ | 3,849 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 09:30:38 | 1.23 | 33,358 | 408.64 | O |
| 09:18:12 | 1.24 | 811 | 10.07 | O |
| 08:48:34 | 1.24 | 805 | 10.00 | O |
| 08:18:37 | 1.17 | 89,348 | 1,046.27 | O |
| 08:03:17 | 1.27 | 100,000 | 1,270.00 | O |
| Top Posts |
|---|
Posted at 08/12/2023 08:20 by Aptamer Daily Update Aptamer Group Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker APTA. The last closing price for Aptamer was 1.25p.Aptamer currently has 467,343,673 shares in issue. The market capitalisation of Aptamer is £5,701,593. Aptamer has a price to earnings ratio (PE ratio) of -0.73. This morning APTA shares opened at 1.23p |
Posted at 30/11/2023 11:07 by intoodeep "This is next generation tech so blue sky"Aptamer Group Plc Ord 0.1p is listed on the London Stock Exchange trading with ticker code APTA.L. It has a market capitalisation of £5.37m, with approximately 467.34m shares in issue. Over the last year, Aptamer Group share price has been traded in a range of 70.00, hitting a high of 71.00, and a low of 1.00. LOFL HONK HONK |
Posted at 23/11/2023 09:09 by intoodeep Aptamer Group Plc Ord 0.1p is listed on the London Stock Exchange trading with ticker code APTA.L. It has a market capitalisation of £5.26m, with approximately 467.34m shares in issue. Over the last year, Aptamer Group share price has been traded in a range of 70.00, hitting a high of 71.00, and a low of 1.00. |
Posted at 08/11/2023 09:58 by intoodeep 18 August 2023 Share Price 1.20p08 November 2023 Share Price 1.20p Ah-Ma-Zing |
Posted at 05/11/2023 12:55 by intoodeep Aptamer Group Plc Ord 0.1p is listed on the London Stock Exchange trading with ticker code APTA.L. It has a market capitalisation of £6.31m, with approximately 467.34m shares in issue. Over the last year, Aptamer Group share price has been traded in a range of 70.00, hitting a high of 71.00, and a low of 1.00. |
Posted at 31/10/2023 10:54 by stevebrrr 9 Oct 2023 09:40RNS Number : 4126PAptamer Group PLC09 October 20239 October 2023Aptamer Group plc("Aptamer", the "Company" or the "Group")Grant of Options and Related Party TransactionAptamer Group plc (AIM: APTA), the developer of novel Optimer® binde |
Posted at 12/10/2023 09:45 by bigruss1 as a share holder i believe in the company but am worried about the lack of updates when can these be expected and will we get results from the company soon thanks keep up the good workMon 4:32 PM Aptamer Group Aptamer Group Hi Russell. Thank you for getting in touch and it's great to hear you believe in the company, as does everyone here. As for updates, please do keep an eye on the RNS feed and also our social media channels as any announcements will be made there. I'm sorry I can't give too much information due to legal reasons, but we are working on forthcoming announcements which you will see in the expected channels. Thanks Piers Aptamer Group Aptamer Group If you have any other questions or would like to speak to the team please get in touch via our email at info@aptamergroup.co You sent thanks for your reply lets hope its good news as i know you have a great team working hard on things |
Posted at 10/10/2023 09:54 by bigruss1 results last year were on the 18 oct and had lots of information on contracts ect .This year bod and nick slater took lots of share plus yesterdays rns on options starting at 4x the share price going up to 50x times the share price what will make it go that high .if they didnt think it was posable that rns yesterday would not of happened ..something big must be in the pipeline for sure .sod the small dilution if this becomes a multi bagger very exciting times here to come imvho |
Posted at 09/10/2023 10:25 by parob 25% dilution only if the share price hits 50p.60% of the options only vest if the prevailing share price reaches 10-times the option exercise price, ie 10p.I would be more than happy should the share price hit 10p for 15% dilution. |
Posted at 09/10/2023 10:09 by intoodeep Letsbuy1, fyi posted on LSE today....sounds about right?It is exceptionally rare to see a BOD make clear its contempt for shareholders as it reiterates the BOD(old school) are bent on taking the maximum returns out of the company at the expense of shareholders. This old school BOD are the ones responsible for the initial failure of the business caused by the plans of a megalomaniac creating an overspend of millions and now they have the gaul to initiate this horrendous 25% gift of the company to themselves at virtually zero cost compared with the loss they created. Giving themselves 25% of the company via dilution is the highest self destructive award to be seen on AIM. Whilst the threat of the 25% DILUTION resides in the background the share price is not going anywhere of consequence. By the retention of the main culprits of the company's failure are still on the BOD and in control of the company don't expect anything else but further daylight robbery. Specifically as they have shot the share price in the foot by having the threat of 25% dilution in the background. Remember each contract is basically short term so renewal of business is essential for their income. The BOD have taken that simple business strategy as a right to justify their extortionate rewards. It becomes obvious this company is not one to invest in for the long term due to the continued and expanded contempt of the BOD towards shareholders. The herd gamblers will on occasion graze on this stock hoping for profits based on news flow until that happens the share price will continue to fade. |
Posted at 05/10/2023 19:15 by parob Amaretto1,That is why I've been building a decent stake over the last few weeks as I think the potential is phenomenal. Current market cap is peanuts and makes them vulnerable to a bid. You could argue the company is closer than its even been to securing licensing revenues especially after the Alzheimer's news a couple of months back. In fact any of the recent fee-for-service contract wins could eventually progress to licensing revenue. The market will react well to any type of contract news, but if they announce a license deal which would "generate material recurring revenue streams" then they should be able to achieve EBITDA and cash break even position much earlier than the year ending 30 June 2025 as currently forecasted and that will attract a different type of investor, not just speculators.At 4p the market cap will still be less than £20M. Share options can be rewarded up to 50 X 1p placing price, ie 50p! As outlined below. They must think it's a possibility to include them at that level.Share Options The Company intends to put in place new share option schemes and to award share options to retain and incentivise the Directors and employees. The number of share options granted will be up to 25 per cent. of the issued share capital as enlarged by the Fundraise. These options will vest subject to stretching performance targets as follows: (a) 16 per cent. on announcement of FY24 audited results in line with expectations and the share price having remained at or above 4 times the Issue Price for at least 3 months; (b) 24 per cent. on announcement of FY25 audited results in line with expectations and the share price having remained at or above 7 times the Issue Price for at least 3 months; (c) 40 per cent. on announcement of FY26 audited results in line with expectations and the share price having remained at or above 10 times the Issue Price for at least 3 months; (d) 10 per cent. on announcement of FY26 audited results in line with expectations and the share price having remained at or above 30 times the Issue Price for at least 3 months; and (e) 10 per cent. on announcement of FY26 audited results in line with expectations and the share price having remained at or above 50 times the Issue Price for at least 3 months.Happy to be patient and see what news lands over the coming weeks and months, but super excited about this one :) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
